AAAAAA
Results: 1-25/65
Authors:
LAUGHLIN MJ
MCGAUGHEY DS
CREWS JR
CHAO NJ
RIZZIERI D
ROSS M
GOCKERMAN J
CIRRINCIONE C
BERRY D
MILLS L
DEFUSCO P
LEGRAND S
PETERS WP
VREDENBURGH JJ
Citation: Mj. Laughlin et al., SECONDARY MYELODYSPLASIA AND ACUTE-LEUKEMIA IN BREAST-CANCER PATIENTSAFTER AUTOLOGOUS BONE-MARROW TRANSPLANT, Journal of clinical oncology, 16(3), 1998, pp. 1008-1012
Authors:
GILBERT CJ
PETROS WP
VREDENBURGH J
HUSSEIN A
ROSS M
RUBIN P
FEHDRAU R
CAVANAUGH C
BERRY D
MCKINSTRY C
PETERS WP
Citation: Cj. Gilbert et al., PHARMACOKINETIC INTERACTION BETWEEN ONDANSETRON AND CYCLOPHOSPHAMIDE DURING HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 497-503
Authors:
PETROS WP
RABINOWITZ J
GIBBS JP
HALL IH
STUART AR
PETERS WP
Citation: Wp. Petros et al., EFFECT OF PLASMA TNF-ALPHA ON FILGRASTIM-STIMULATED HEMATOPOIESIS IN MICE AND HUMANS, Pharmacotherapy, 18(4), 1998, pp. 816-823
Authors:
FISHER DC
VREDENBURGH JJ
PETROS WP
HUSSEIN A
BERRY DA
ELKORDY M
RUBIN P
GILBERT CJ
PETERS WP
Citation: Dc. Fisher et al., REDUCED MORTALITY FOLLOWING BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER WITH THE ADDITION OF PERIPHERAL-BLOOD PROGENITOR CELLS IS DUE TO A MARKED REDUCTION IN VENOOCCLUSIVE DISEASE OF THE LIVER, Bone marrow transplantation, 21(2), 1998, pp. 117-122
Authors:
DU W
DANSEY R
ABELLA EM
BAYNES R
PETERS WP
KLEIN J
AKHTAR A
CHEREDNIKOVA L
KARANES C
Citation: W. Du et al., SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SELECTED PATIENTS OVER 50 YEARS OF AGE - A SINGLE INSTITUTIONS EXPERIENCE, Bone marrow transplantation, 21(10), 1998, pp. 1043-1047
Authors:
ALPERT LC
SCHECTER RL
BERRY DA
MELNYCHUK D
PETERS WP
CARUSO JA
TOWNSEND AJ
BATIST G
Citation: Lc. Alpert et al., RELATION OF GLUTATHIONE-S-TRANSFERASE ALPHA-ISOFORM AND MU-ISOFORM TORESPONSE TO THERAPY IN HUMAN BREAST-CANCER, Clinical cancer research, 3(5), 1997, pp. 661-667
Authors:
PETROS WP
RABINOWITZ J
STUART A
PETERS WP
Citation: Wp. Petros et al., CLINICAL-PHARMACOLOGY OF FILGRASTIM FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Clinical cancer research, 3(5), 1997, pp. 705-711
Authors:
PETERS WP
DANSEY R
Citation: Wp. Peters et R. Dansey, NEW CONCEPTS IN THE TREATMENT OF BREAST-CANCER USING HIGH-DOSE CHEMOTHERAPY, Cancer chemotherapy and pharmacology, 40, 1997, pp. 88-93
Authors:
ELKORDY M
CRUMP M
VREDENBURGH JJ
PETROS WP
HUSSEIN A
RUBIN P
ROSS M
GILBERT C
MODLIN C
MEISENBERG B
CONIGLIO D
RABINOWITZ J
LAUGHLIN M
KURTZBERG J
PETERS WP
Citation: M. Elkordy et al., A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (OCT-43) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 315-322
Authors:
DANSEY R
KLEIN J
KARANES C
AKHTAR A
CASSELLS L
PETERS WP
BAYNES RD
Citation: R. Dansey et al., SUCCESSFUL PERIPHERAL-BLOOD MOBILIZATION OF CD34 PROGENITOR CELLS BY CYCLOPHOSPHAMIDE, PACLITAXEL AND G-CSF AFTER FAILURE WITH G-CSF ALONE, Blood, 90(10), 1997, pp. 428-428
Authors:
DU W
DANSEY R
ABELLA EM
BAYNES R
PETERS WP
KLEIN J
AKHTAR A
CHEREDNIKOVA L
KARANES C
Citation: W. Du et al., SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SELECTED PATIENTS OVER 50 YEARS OF AGE - A SINGLE INSTITUTION EXPERIENCE, Blood, 90(10), 1997, pp. 1656-1656
Authors:
TYER CL
VREDENBURGH JJ
HEIMER M
PETERS WP
BAST RC
Citation: Cl. Tyer et al., BREAST-CANCER CELLS ARE EFFECTIVELY PURGED FROM PERIPHERAL-BLOOD PROGENITOR CELLS WITH AN IMMUNOMAGNETIC TECHNIQUE, Clinical cancer research, 2(1), 1996, pp. 81-86
Authors:
LAWRENCE CC
GILBERT CJ
PETERS WP
Citation: Cc. Lawrence et al., EVALUATION OF SYMPTOM DISTRESS IN A BONE-MARROW TRANSPLANT OUTPATIENTENVIRONMENT, The Annals of pharmacotherapy, 30(9), 1996, pp. 941-945
Authors:
HUSSEIN AM
PETROS WP
ROSS M
VREDENBURGH JJ
AFFRONTI ML
JONES RB
SHPALL EJ
RUBIN P
ELKORDY M
GILBERT C
GUPTON C
EGORIN MJ
SOPER J
BERCHUCK A
CLARKEPEARSON D
BERRY DA
PETERS WP
Citation: Am. Hussein et al., A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 561-568
Authors:
HUSSEIN A
VREDENBURGH J
ELKORDY M
RUBIN P
FISHER D
CANALES R
PETROS W
GILBERT C
PERET N
DYKSTRA K
LOEWY J
KAYE JA
PETERS WP
Citation: A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634
Authors:
PETROS WP
ROSNER GL
RABINOWITZ J
GILBERT CJ
CONIGLIO D
VREDENBURGH JJ
ROSS M
PETERS WP
Citation: Wp. Petros et al., THE PHARMACOLOGICAL EFFECTS OF RECOMBINANT, HUMAN COLONY-STIMULATING FACTORS AND THEIR MODULATION BY THEOPHYLLINE, Pharmacotherapy, 16(5), 1996, pp. 742-748
Authors:
FISHER DC
SHERRILL GB
HUSSEIN A
RUBIN P
VREDENBURGH JJ
ELKORDY M
ROSS M
PETROS W
PETERS WP
Citation: Dc. Fisher et al., THROMBOTIC MICROANGIOPATHY AS A COMPLICATION OF HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER, Bone marrow transplantation, 18(1), 1996, pp. 193-198
Authors:
RUBIN P
HULETTE C
KHAWLY JA
ELKORDY M
HUSSEIN A
VREDENBURGH JJ
JAFFE GJ
PETERS WP
Citation: P. Rubin et al., OCULAR TOXICITY FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANT, Bone marrow transplantation, 18(1), 1996, pp. 253-256
Authors:
KHAWLY JA
RUBIN P
PETROS W
PETERS WP
JAFFE GJ
Citation: Ja. Khawly et al., RETINOPATHY AND OPTIC NEUROPATHY IN BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER, Ophthalmology, 103(1), 1996, pp. 87-95
Authors:
VREDENBURGH J
RUBIN P
ELKORDY M
CREWS J
PETERS WP
LEGRAND S
DEFUSCO P
Citation: J. Vredenburgh et al., SECONDARY MYELODYSPLASIA (MDS) ACUTE LEUKEMIA (AL) AFTER HIGH-DOSE CHEMOTHERAPY FOR METASTIC BREAST-CANCER/, Blood, 88(10), 1996, pp. 1034-1034
Authors:
HUSSEIN AM
ELKORDY M
PETERS WP
Citation: Am. Hussein et al., THE USE OF GROWTH-FACTORS WITH ANTIBIOTICS IN THE SETTING OF NEUTROPENIC FEVER, The American journal of medicine, 100(1), 1996, pp. 15-16
Authors:
CARTEE L
PETROS WP
ROSNER GL
GILBERT C
MOORE S
AFFRONTI ML
HOKE JA
HUSSEIN AM
ROSS M
RUBIN P
VREDENBURGH JJ
PETERS WP
Citation: L. Cartee et al., EVALUATION OF GM-CSF MOUTHWASH FOR PREVENTION OF CHEMOTHERAPY-INDUCEDMUCOSITIS - A RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY, Cytokine, 7(5), 1995, pp. 471-477
Authors:
HUSSEIN AM
STUART A
PETERS WP
Citation: Am. Hussein et al., PROTECTION AGAINST CHEMOTHERAPY-INDUCED ALOPECIA BY CYCLOSPORINE-A INTHE NEWBORN RAT ANIMAL-MODEL, Dermatology, 190(3), 1995, pp. 192-196
Authors:
HUSSEIN AM
ROSS M
VREDENBURGH J
MEISENBERG B
HARS V
GILBERT C
PETROS WP
CONIGLIO D
KURTZBERG J
RUBIN P
PETERS WP
Citation: Am. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, European journal of haematology, 54(5), 1995, pp. 281-287
Authors:
MUDAD R
HUSSEIN A
PETERS WP
Citation: R. Mudad et al., GUILLAIN-BARRE-SYNDROME FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, American journal of clinical oncology, 18(2), 1995, pp. 167-169